Skip to main content

Table 1 Description of neuropsychological and clinical efficacy outcome measures

From: Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)

Abbreviation Full Name Description Reference
Neuropsychological Measures    
 HVLT-R Hopkins Verbal Learning Test – Revised Anterograde verbal learning and memory assessment [47]
 AMI-SF Autobiographical Memory Inventory – Short Form Retrograde assessment of personal memories [59]
 COWAT – letter and category Controlled Oral Word Association Test Letter and Category fluency assessment [60]
 MCG – Complex Figure Test Medical College of Georgia Complex Figure Test Anterograde visuospatial memory assessment [61]
 Digit Span Digit Span Working memory assessment [62]
 GSE-My Global Self-Evaluation of Memory Self-reported assessment of memory [63]
 Reorientation Reorientation Number of 5 orientation items correct 30 and 60 min after ECT [64]
Clinical Efficacy Measures    
 MADRS Montgomery-Åsberg Depression Rating Scale Observer-rated assessment of depressive symptoms [48]
 CAS Clinical Anxiety Scale Observer-rated assessment of anxiety symptoms [65]
 BPRS Brief Psychiatric Rating Scale Observer-rated assessment of psychiatric symptoms [66]
 CGI-S, CGI-I Clinical Global Impression – Severity and Improvement Observer-rated global measure of illness severity and improvement [67]
 QIDS-SR Quick Inventory Depressive Symptomology – Self Rated Self-rated measure of depressive symptoms [68]
 EQ-5D EuroQol Self-rated measure of health-related quality of life [69]